Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations
#1PRI RANKED
Most Cited Paper
in Acute Myeloid Leukemia Research
18 Months Post-Publication
Class of 2026
“Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
European LeukemiaNet (ELN) · European LeukemiaNet (ELN) risk classification · Acute myeloid leukemia (AML) · Low-intensity therapy · Intensive chemotherapy · younger adults with AML · 2024 ELN recommendations · Risk stratification · treatment-specific risk assessment
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026. Accessed 2026-07-31. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459